Logo image of BZ

KANZHUN LTD - ADR (BZ) Stock Fundamental Analysis

NASDAQ:BZ - Nasdaq - US48553T1060 - ADR - Currency: USD

15.255  +0.12 (+0.76%)

Fundamental Rating

6

Overall BZ gets a fundamental rating of 6 out of 10. We evaluated BZ against 70 industry peers in the Interactive Media & Services industry. BZ has an excellent financial health rating, but there are some minor concerns on its profitability. BZ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BZ had positive earnings in the past year.
BZ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BZ reported negative net income in multiple years.
BZ had a positive operating cash flow in each of the past 5 years.
BZ Yearly Net Income VS EBIT VS OCF VS FCFBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

BZ has a Return On Assets of 8.21%. This is amongst the best in the industry. BZ outperforms 87.14% of its industry peers.
BZ has a better Return On Equity (10.66%) than 88.57% of its industry peers.
BZ has a better Return On Invested Capital (6.81%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA 8.21%
ROE 10.66%
ROIC 6.81%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
BZ Yearly ROA, ROE, ROICBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BZ has a better Profit Margin (21.54%) than 90.00% of its industry peers.
The Operating Margin of BZ (15.95%) is better than 82.86% of its industry peers.
BZ has a better Gross Margin (83.15%) than 78.57% of its industry peers.
In the last couple of years the Gross Margin of BZ has remained more or less at the same level.
Industry RankSector Rank
OM 15.95%
PM (TTM) 21.54%
GM 83.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
BZ Yearly Profit, Operating, Gross MarginsBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BZ is destroying value.
The number of shares outstanding for BZ remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BZ has more shares outstanding
There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BZ Yearly Shares OutstandingBZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BZ Yearly Total Debt VS Total AssetsBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

BZ has an Altman-Z score of 7.75. This indicates that BZ is financially healthy and has little risk of bankruptcy at the moment.
BZ's Altman-Z score of 7.75 is amongst the best of the industry. BZ outperforms 87.14% of its industry peers.
There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.75
ROIC/WACC0.9
WACC7.54%
BZ Yearly LT Debt VS Equity VS FCFBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 3.60 indicates that BZ has no problem at all paying its short term obligations.
BZ has a Current ratio of 3.60. This is in the better half of the industry: BZ outperforms 78.57% of its industry peers.
BZ has a Quick Ratio of 3.60. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of BZ (3.60) is better than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
BZ Yearly Current Assets VS Current LiabilitesBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5B 10B 15B

6

3. Growth

3.1 Past

BZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.90%, which is quite impressive.
The Revenue has grown by 23.58% in the past year. This is a very strong growth!
Measured over the past years, BZ shows a very strong growth in Revenue. The Revenue has been growing by 49.09% on average per year.
EPS 1Y (TTM)24.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.67%
Revenue 1Y (TTM)23.58%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%15.4%

3.2 Future

BZ is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.51% yearly.
BZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.58% yearly.
EPS Next Y24.16%
EPS Next 2Y19.92%
EPS Next 3Y18.33%
EPS Next 5Y-2.51%
Revenue Next Year12.96%
Revenue Next 2Y13.13%
Revenue Next 3Y12.78%
Revenue Next 5Y12.58%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BZ Yearly Revenue VS EstimatesBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
BZ Yearly EPS VS EstimatesBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.60 indicates a rather expensive valuation of BZ.
Based on the Price/Earnings ratio, BZ is valued a bit cheaper than 68.57% of the companies in the same industry.
BZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.98.
A Price/Forward Earnings ratio of 14.97 indicates a correct valuation of BZ.
71.43% of the companies in the same industry are more expensive than BZ, based on the Price/Forward Earnings ratio.
BZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 18.6
Fwd PE 14.97
BZ Price Earnings VS Forward Price EarningsBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BZ indicates a somewhat cheap valuation: BZ is cheaper than 77.14% of the companies listed in the same industry.
BZ's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BZ is cheaper than 65.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.22
EV/EBITDA 12.99
BZ Per share dataBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BZ has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BZ's earnings are expected to grow with 18.33% in the coming years.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y19.92%
EPS Next 3Y18.33%

0

5. Dividend

5.1 Amount

BZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KANZHUN LTD - ADR

NASDAQ:BZ (4/30/2025, 3:58:03 PM)

15.255

+0.12 (+0.76%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)03-11 2025-03-11/bmo
Earnings (Next)05-19 2025-05-19/bmo
Inst Owners75.9%
Inst Owner Change2.18%
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap6.73B
Analysts82.14
Price Target21 (37.66%)
Short Float %10.05%
Short Ratio3.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.38%
Min EPS beat(2)-0.61%
Max EPS beat(2)9.37%
EPS beat(4)3
Avg EPS beat(4)7.36%
Min EPS beat(4)-0.61%
Max EPS beat(4)18.64%
EPS beat(8)7
Avg EPS beat(8)19.81%
EPS beat(12)10
Avg EPS beat(12)273.42%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)-1.57%
Revenue beat(4)0
Avg Revenue beat(4)-1.9%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)-0.6%
Revenue beat(8)3
Avg Revenue beat(8)-0.87%
Revenue beat(12)3
Avg Revenue beat(12)-1.01%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.81%
PT rev (3m)25.36%
EPS NQ rev (1m)0.33%
EPS NQ rev (3m)15.14%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-2.43%
Revenue NY rev (1m)0.74%
Revenue NY rev (3m)0.72%
Valuation
Industry RankSector Rank
PE 18.6
Fwd PE 14.97
P/S 6.65
P/FCF 18.22
P/OCF 13.82
P/B 3.29
P/tB 3.35
EV/EBITDA 12.99
EPS(TTM)0.82
EY5.38%
EPS(NY)1.02
Fwd EY6.68%
FCF(TTM)0.84
FCFY5.49%
OCF(TTM)1.1
OCFY7.24%
SpS2.29
BVpS4.63
TBVpS4.55
PEG (NY)0.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.21%
ROE 10.66%
ROCE 7.76%
ROIC 6.81%
ROICexc 235.22%
ROICexgc 576.89%
OM 15.95%
PM (TTM) 21.54%
GM 83.15%
FCFM 36.52%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
F-Score9
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 170.57%
Cap/Sales 11.64%
Interest Coverage 250
Cash Conversion 211.51%
Profit Quality 169.53%
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z 7.75
F-Score9
WACC7.54%
ROIC/WACC0.9
Cap/Depr(3y)260.87%
Cap/Depr(5y)288.66%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.69%
Profit Quality(3y)326.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.67%
EPS Next Y24.16%
EPS Next 2Y19.92%
EPS Next 3Y18.33%
EPS Next 5Y-2.51%
Revenue 1Y (TTM)23.58%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%15.4%
Revenue Next Year12.96%
Revenue Next 2Y13.13%
Revenue Next 3Y12.78%
Revenue Next 5Y12.58%
EBIT growth 1Y101.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.97%
EBIT Next 3Y24.82%
EBIT Next 5Y19.2%
FCF growth 1Y28.45%
FCF growth 3Y24.82%
FCF growth 5YN/A
OCF growth 1Y16.26%
OCF growth 3Y29.23%
OCF growth 5YN/A